Search - tctmd.com

Displaying 1 - 20 of 87

Sort: Relevancy | Date

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Opinion Editor's Corner TCT 2017

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Shelley Wood

November 22, 2017

News Conference News AHA 2017

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Michael O'Riordan

November 21, 2017

News Conference News AHA 2017

TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery

Shelley Wood

November 12, 2017

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

News Conference News TCT 2017

Early Pilot Study Results Show Symptom Improvement With TMVR

Michael O'Riordan

November 07, 2017

Presentation TCT 2017

RV-PA Conduit Dysfunction: The History of Transcatheter PV Therapy

Presenter: Elchanan Bruckheimer, Doff B. McElhinney, Michael J. Mullen

November 01, 2017

News Conference News TCT 2017

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

Michael O'Riordan

October 31, 2017

Presentation TCT 2017

The Compelling Saga of Stroke after TAVR: Key Messages From NeuroARC

Presenter: Michael J. Reardon, Didier Tchetche, Alexandra J. Lansky

October 31, 2017

Presentation TCT 2017

Musings on TMVR Patient Selection Criteria to Date, and Which Patients Should Be Put in TMVR Trials Rather Than Treated Clinically With Current Devices

Presenter: Howard C. Herrmann, Michael J. Mack

October 31, 2017

Presentation TCT 2017

Emerging TMVR 5: Mitraltech - Device Description, Critical Appraisal, and Development Plans

Presenter: Howard C. Herrmann, Michael J. Mack, Francesco Maisano

October 31, 2017

Presentation TCT 2017

Emerging TMVR 4: Corona Valve With Amend Ring - Device Description, Critical Appraisal, and Development Plans

Presenter: Howard C. Herrmann, Michael J. Mack, David Meerkin

October 31, 2017

Presentation TCT 2017

Emerging TMVR 3: M-Dock - Device Description, Critical Appraisal, and Development Plans

Presenter: Howard C. Herrmann, Michael J. Mack, Maurice Buchbinder

October 31, 2017

Presentation TCT 2017

Emerging TMVR 2: 4C - Device Description, Critical Appraisal, and Development Plans

Presenter: Howard C. Herrmann, Michael J. Mack, Philippe Genereux

October 31, 2017

Presentation TCT 2017

Established TMVR 6: Caisson - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Mathew Williams

October 31, 2017

Presentation TCT 2017

Established TMVR 5: Highlife - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Nicolo Piazza

October 31, 2017

Presentation TCT 2017

Established TMVR 4: Intrepid - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Vinayak Bapat

October 31, 2017

Presentation TCT 2017

Established TMVR 3: Tendyne - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, David W.M. Muller

October 31, 2017

Presentation TCT 2017

Established TMVR 2: Tiara - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Anson Cheung

October 31, 2017

Presentation TCT 2017

Established TMVR 1: Cardiaq - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, James B. Hermiller Jr.

October 31, 2017

Advertisement

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Early Pilot Study Results Show Symptom Improvement With TMVR

RV-PA Conduit Dysfunction: The History of Transcatheter PV Therapy

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

The Compelling Saga of Stroke after TAVR: Key Messages From NeuroARC

Musings on TMVR Patient Selection Criteria to Date, and Which Patients Should Be Put in TMVR Trials Rather Than Treated Clinically With Current Devices

Emerging TMVR 5: Mitraltech - Device Description, Critical Appraisal, and Development Plans

Emerging TMVR 4: Corona Valve With Amend Ring - Device Description, Critical Appraisal, and Development Plans

Emerging TMVR 3: M-Dock - Device Description, Critical Appraisal, and Development Plans

Emerging TMVR 2: 4C - Device Description, Critical Appraisal, and Development Plans

Established TMVR 6: Caisson - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Established TMVR 5: Highlife - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Established TMVR 4: Intrepid - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Established TMVR 3: Tendyne - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Established TMVR 2: Tiara - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Established TMVR 1: Cardiaq - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content